- Home
- AG vs BAX Comparison
AG vs BAX Comparison
Compare AG & BAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | AG | BAX |
|---|---|---|
| Founded | 1979 | 1931 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Precious Metals | Medical/Dental Instruments |
| Sector | Basic Materials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.2B | 10.2B |
| IPO Year | 2004 | 1994 |
Fundamental Metrics
Financial Performance| Metric | AG | BAX |
|---|---|---|
| Price | $25.71 | $18.06 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 3 | 9 |
| Target Price | $21.92 | ★ $22.13 |
| AVG Volume (30 Days) | ★ 19.1M | 9.4M |
| Earning Date | 01-01-0001 | 05-14-2026 |
| Dividend Yield | 0.09% | ★ 0.22% |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $11,244,000,000.00 |
| Revenue This Year | $13.75 | $1.90 |
| Revenue Next Year | $26.43 | $2.09 |
| P/E Ratio | $143.01 | ★ N/A |
| Revenue Growth | N/A | ★ 5.72 |
| 52 Week Low | $5.19 | $17.07 |
| 52 Week High | $32.00 | $35.03 |
Technical Indicators
Market Signals| Indicator | AG | BAX |
|---|---|---|
| Relative Strength Index (RSI) | 49.15 | 37.46 |
| Support Level | $20.21 | $17.69 |
| Resistance Level | $27.90 | $19.31 |
| Average True Range (ATR) | 1.73 | 0.71 |
| MACD | -0.57 | -0.34 |
| Stochastic Oscillator | 12.64 | 19.91 |
Price Performance
Historical ComparisonAbout AG First Majestic Silver Corp. (Canada)
First Majestic Silver Corp is engaged in the production, development, exploration, and acquisition of mineral properties with a focus on silver and gold production in North America. It owns three producing mines in Mexico consisting of the San Dimas Silver/Gold Mine, the Santa Elena Silver/Gold Mine, and the La Encantada Silver Mine.
About BAX Baxter International Inc.
Baxter offers a variety of medical supplies and equipment to providers. From its legacy operations, Baxter sells injectable therapies for use in care settings, including IV pumps, administrative sets, and solutions; nutritional products; and surgical sealants and hemostatic agents. Baxter expanded its portfolio of hospital-focused offerings by acquiring Hillrom in late 2021, which added basic equipment like hospital beds, operating room equipment, and patient monitoring tools to the portfolio. Baxter also sold its kidney care tools in early 2025.